Search
Close modal
Focus
Compare
Peers
ZURN.SW
Compare to NOVN.SW
vs. NOVN.SW
NESN.SW
Compare to NOVN.SW
vs. NOVN.SW
UBSG.SW
Compare to NOVN.SW
vs. NOVN.SW
ROG.SW
Compare to NOVN.SW
vs. NOVN.SW
SREN.SW
Compare to NOVN.SW
vs. NOVN.SW
Individuals
Nadella Satya - Transcribed Opinions
Rogers Jeff - Insider Activity
We use cookies
to analyze our traffic and create a smooth user experience.
Manage
Accept
Add NOVN.SW to watchlist(s)
Close modal
You Should
Create a Watchlist
In The First Place.
Subsidiaries
Close modal
Company
Subsidiaries
Close modal
Locations
Toggle Sidebar
/
Stocks
/
CH
/
Basel
/
Healthcare
/
Drug Manufacturers - General
/
NOVN.SW
Toggle Sidebar
Add To Watchlist
About
Docs
Document Index
Analysing NOVN.SW
Close modal
Summary
Investor Relations
Financial Reporting
Income Statements
Cash Flow Statements
Balance Sheets
Resulting Ratios
Financials
Analysts
Dividend Payments
Government Awards
Insiders
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Leadership & Strategy
Board & Officers
Business Intelligence
Employee Voice
M&A
Qualified Risks
Possible Catalysts
H1B/PERM Strategy
Macro
News
Peer Performance
Novartis AG
96.31
CHF/USD
-1.57
(-1.60%)
18.49
P/E
5.21
EPS
182.76 B
MCap.
Market Cap.
1.9 B
Shares
Out.
Outstanding
Overview
Fin.
Financial
Statements
Financials
Leadership & Strategy
Possible Catalysts
